Insights

Growing Market Presence Angelini Pharma aims to become a leading European player in the pharmaceutical industry with a strong focus on CNS and mental health disorders, presenting opportunities for partnerships and sales in these specialized medical areas.

Innovative Pipeline The company's recent development of SVG105 for brain health and strategic collaborations, such as with Sovargen, indicates an active pipeline focused on advanced therapies, ideal for companies seeking innovative treatment solutions.

Focus on Mental Health With ongoing engagement in epilepsy and seizure control initiatives, Angelini Pharma is positioned as a key stakeholder in neurological disorder markets, offering opportunities to introduce complementary products or services.

Financial Stability & Growth With revenues between 100 million and 1 billion dollars and steady funding, Angelini Pharma demonstrates financial stability, making it a reliable partner for larger-scale collaborations and long-term sales strategies.

Recognition & Engagement Recognition as a top employer and active participation in industry congresses emphasize Angelini Pharma’s commitment to innovation and workforce excellence, providing a fertile environment for strategic alliances and business expansion.

Angelini Pharma Tech Stack

Angelini Pharma uses 8 technology products and services including Open Graph, OWL Carousel, Modernizr, and more. Explore Angelini Pharma's tech stack below.

Open Graph

Content Management System

OWL Carousel

Javascript Libraries

Modernizr

Javascript Libraries

Salesforce Marketing Cloud Account Engagement

Marketing Automation

Priority Hints

Performance

Java

Programming Languages

Google Analytics

Web Analytics

Magnific Popup

Web Tools And Plugins

Angelini Pharma Email Formats	Example	Percentage
First.Last@angelinipharma.com	John.Doe@angelinipharma.com	98%
First.Middle@angelinipharma.com	John.Michael@angelinipharma.com	1%
Last.First@angelinipharma.com	Doe.John@angelinipharma.com	1%

Angelini Pharma Email Formats

Example

Percentage

First.Last@angelinipharma.com

John.Doe@angelinipharma.com

98%

First.Middle@angelinipharma.com

John.Michael@angelinipharma.com

Last.First@angelinipharma.com

Doe.John@angelinipharma.com

Frequently Asked Questions

Where is Angelini Pharma's headquarters located?

Angelini Pharma's main headquarters is located at Viale Amelia, 70, Rome, RM 00181, IT. The company has employees across 3 continents, including EuropeAsiaNorth America.

What is Angelini Pharma's official website and social media links?

Angelini Pharma's official website is angelinipharma.com and has social profiles on LinkedIn Crunchbase.

How much revenue does Angelini Pharma generate?

As of October 2025, Angelini Pharma's annual revenue is estimated to be $890M.

What is Angelini Pharma's NAICS code?

Angelini Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Angelini Pharma have currently?

As of October 2025, Angelini Pharma has approximately 5K employees across 3 continents, including EuropeAsiaNorth America. Key team members include Chief Scientific Officer, Global R&d Head, Executive Committee Member: R. K.Chief Medical Officer: A. C.Chief Business Development Officer: A. M.. Explore Angelini Pharma's employee directory with LeadIQ.

What industry does Angelini Pharma belong to?

Angelini Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does Angelini Pharma use?

Angelini Pharma's tech stack includes Open GraphOWL CarouselModernizrSalesforce Marketing Cloud Account EngagementPriority HintsJavaGoogle AnalyticsMagnific Popup.

What is Angelini Pharma's email format?

Angelini Pharma's email format typically follows the pattern of First.Last@angelinipharma.com. Find more Angelini Pharma email formats with LeadIQ.

How much funding has Angelini Pharma raised to date?

As of October 2025, Angelini Pharma has raised $1.7M in funding. The last funding round occurred on Jul 13, 2023 for $1.7M.

Angelini Pharma

Pharmaceutical ManufacturingItaly5001-10000 Employees

At Angelini Pharma, we work every day to grow as a leading Pharma Company that makes a difference in patients’ life. Since 1919. 
We aim at becoming a leading European player, offering people, patients and their beloved ones new medicines and solutions to achieve better health outcomes and higher quality of life. 
We make our vision real through robust pipeline growth, strong collaborations with best-in-class Research Institutes and valuable partnerships with our strategic allies.
We pledge to successfully develop distinctive treatments for CNS and Mental Health disorders while preserving our leading position in the Consumer Health segment.
Angelini Pharma is part of Angelini Industries.

Social media privacy notice: https://bit.ly/socialmediaprivacynotice

Insights

Similar companies to Angelini Pharma

Hikma Pharmaceuticals

Bayer | Pharmaceuticals

Teva Pharmaceuticals

MENARINI Group

Ipsen

Recordati

Mayne Pharma

Krka

Angelini Pharma Tech Stack

Media & News

Angelini Pharma is developing SVG105 for the treatment of brain health disorders.

Angelini Pharma sold assets to Meridiacapital in the amount of $11.7M on Dec 31st '21.

Angelini Pharma attends event EAN Congress 2025.

GRIN Therapeutics Inc. partners with Angelini Pharma.

Angelini Pharma attends event 2024 EEC Congress (European Epilepsy Congress).

Angelini Pharma attends event International Epilepsy Day.

Angelini Pharma recognized as Top Employer certification.

Angelini Pharma's Email Address Formats